Windlas Biotech Ltd
NSE :WINDLAS BSE :543329 Sector : PharmaceuticalsBuy, Sell or Hold WINDLAS? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
21 Mar 924.15 (0.49%) | 20 Mar 919.60 (-0.20%) | 19 Mar 921.40 (2.13%) | 18 Mar 902.20 (3.33%) | 17 Mar 873.10 (-2.23%) | 13 Mar 893.00 (0.52%) | 12 Mar 888.35 (-4.89%) | 11 Mar 934.00 (1.96%) | 10 Mar 916.05 (-0.87%) | 07 Mar 924.05 (2.35%) | 06 Mar 902.85 (2.08%) | 05 Mar 884.45 (-0.77%) | 04 Mar 891.30 (7.84%) | 03 Mar 826.50 (8.32%) | 28 Feb 763.00 (-3.82%) | 27 Feb 793.30 (-3.35%) | 25 Feb 820.80 (0.94%) | 24 Feb 813.15 (2.85%) | 21 Feb 790.60 (-0.91%) | 20 Feb 797.90 (18.15%) | 19 Feb 675.35 (-7.47%) |
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Neutral
Long Term Investors

Very Bullish
Moving Averages
5 DMA
Bullish
908.3
10 DMA
Bullish
910.24
20 DMA
Bullish
868.75
50 DMA
Bullish
908.55
100 DMA
Bearish
977.02
200 DMA
Bullish
895.07
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Mar 21, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 965.84 | 951.42 | 931.86 | - | - |
R2 | 951.42 | 940.7 | 929.29 | 951.61 | - |
R1 | 937.79 | 934.09 | 926.72 | 938.17 | 944.6 |
P | 923.37 | 923.37 | 923.37 | 923.56 | 926.78 |
S1 | 909.74 | 912.65 | 921.58 | 910.12 | 916.55 |
S2 | 895.32 | 906.04 | 919.01 | 895.51 | - |
S3 | 881.69 | 895.32 | 916.44 | - | - |
Key Metrics
EPS
29.34
P/E
31.45
P/B
4.09
Dividend Yield
0.59%
Market Cap
1,932 Cr.
Face Value
5
Book Value
225.63
ROE
13.66%
EBITDA Growth
27.74 Cr.
Debt/Equity
0.01
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Windlas Biotech Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 165.38 | 175.73 | 179.29 | 191.84 | 199.13 | |
PROFIT | 15.1 | 16.99 | 13.48 | 15.66 | 15.58 | |
EPS | 7.26 | 8.17 | 6.47 | 7.49 | 7.45 |
Windlas Biotech Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 165.38 | 175.73 | 179.29 | 191.84 | 198.75 | |
PROFIT | 15.1 | 16.95 | 13.48 | 15.66 | 15.23 | |
EPS | 7.26 | 8.15 | 6.47 | 7.49 | 7.29 |
Profit & Loss (Figures in Rs. Crores)
Windlas Biotech Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 354.19 | 357.42 | 344.09 | 432.67 | 477.38 | 538.32 | 634.84 | |
PROFIT | 11.19 | 22.25 | 16.22 | 31.31 | 38.08 | 41.98 | 58.19 | |
EPS | 0 | 0 | 0 | 0 | 17.48 | 20.37 | 27.98 |
Windlas Biotech Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 265.58 | 265.54 | 325.2 | 320.35 | 286.86 | 342.56 | 427.02 | 477.38 | 538.32 | 634.84 | |
PROFIT | 5.58 | 4.55 | 9.17 | 15.72 | 22.12 | 22.46 | 19.5 | 38.55 | 41.99 | 58.14 | |
EPS | 11.16 | 8.14 | 16.4 | 30.25 | 35.05 | 35.03 | 7.81 | 17.69 | 20.38 | 27.96 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 10.4 | 10.46 | 10.9 | 6.41 | 6.41 | 6.41 | 5.59 |
Reserves Total | 439.54 | 391.81 | 383.88 | 192.71 | 203.25 | 187.17 | 116.51 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 2.94 |
Total Shareholders Funds | 449.94 | 402.27 | 394.78 | 199.12 | 209.66 | 193.58 | 125.04 |
Secured Loans | 0.11 | 0.44 | 6.12 | 30.24 | 27.43 | 29.91 | 55.11 |
Unsecured Loans | 3.53 | 4.55 | 0.52 | 2.11 | 1.5 | 1.93 | 2.32 |
Total Debt | 3.64 | 4.99 | 6.64 | 32.35 | 28.93 | 31.84 | 57.43 |
Other Liabilities | 2.5 | 2.34 | 1.8 | 1.55 | 1.29 | 1.06 | 1.69 |
Total Liabilities | 456.08 | 409.6 | 403.22 | 233.02 | 239.88 | 226.48 | 184.16 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 273.89 | 193.46 | 163.87 | 157 | 79.35 | 84.85 | 103.81 |
Less: Accumulated Depreciation | 94.85 | 84.05 | 72.69 | 61.06 | 9.09 | 20.59 | 17.32 |
Net Block | 179.04 | 109.41 | 91.18 | 95.94 | 70.26 | 64.26 | 86.49 |
Capital Work in Progress | 5.71 | 14.78 | 8.01 | 0.04 | 0 | 4.58 | 52.56 |
Investments | 173.44 | 106.51 | 64.82 | 23.14 | 116.28 | 122.35 | 22.57 |
Inventories | 62.19 | 74.74 | 58.71 | 41.46 | 49.32 | 19.03 | 35.05 |
Sundry Debtors | 136.28 | 116.86 | 110.77 | 79.41 | 63.94 | 61.74 | 66.59 |
Cash and Bank Balance | 30.95 | 25.45 | 113.82 | 31.11 | 18.38 | 13.2 | 7.66 |
Loans and Advances | 28.44 | 29.97 | 33.52 | 19.19 | 14.11 | 5.61 | 12.26 |
Total Current Assets | 257.85 | 247.03 | 316.83 | 171.17 | 145.75 | 99.56 | 121.57 |
Current Liabilities | 169.4 | 118.34 | 87.46 | 62.13 | 98.19 | 67.43 | 100.47 |
Provisions | 0.73 | 1.04 | 0.33 | 0.28 | 0.41 | 4.26 | 5.26 |
Total Current Liabilities & Provisions | 170.12 | 119.37 | 87.79 | 62.42 | 98.6 | 71.69 | 105.72 |
Net Current Assets | 87.73 | 127.65 | 229.04 | 108.76 | 47.15 | 27.88 | 15.85 |
Deferred Tax Assets | 3.32 | 3.65 | 3.07 | 1.32 | 2.7 | 2.89 | 2.81 |
Deferred Tax Liability | 2.75 | 1.63 | 1.04 | 2.01 | 2.04 | 2.39 | 2.07 |
Net Deferred Tax | 0.57 | 2.02 | 2.03 | -0.69 | 0.66 | 0.5 | 0.74 |
Other Assets | 9.59 | 49.23 | 8.13 | 5.84 | 5.53 | 6.92 | 5.96 |
Total Assets | 456.09 | 409.6 | 403.22 | 233.03 | 239.88 | 226.49 | 184.16 |
Contingent Liabilities | 0 | 0 | 2.53 | 0 | 0 | 0 | 0 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 10.4 | 10.46 | 10.9 | 6.41 | 6.41 | 6.41 | 8.53 | 8.53 | 8.53 | 5 |
Reserves Total | 439.89 | 392.2 | 384.23 | 192.58 | 210.07 | 187.61 | 158.2 | 141.3 | 132.13 | 59.03 |
Total Shareholders Funds | 450.29 | 402.66 | 395.13 | 198.99 | 216.48 | 194.02 | 166.73 | 149.83 | 140.66 | 64.03 |
Secured Loans | 0.11 | 0.44 | 6.12 | 30.24 | 22.16 | 22.89 | 30.01 | 51.41 | 43.96 | 71.48 |
Unsecured Loans | 3.53 | 4.55 | 0.52 | 2.11 | 5.27 | 7.02 | 9.59 | 8.12 | 6.07 | 5.87 |
Total Debt | 3.64 | 4.99 | 6.64 | 32.35 | 27.43 | 29.91 | 39.6 | 59.53 | 50.03 | 77.35 |
Other Liabilities | 2.5 | 2.34 | 1.8 | 1.55 | 1.19 | 1.06 | 0.89 | 0.84 | 0.59 | 0.55 |
Total Liabilities | 456.43 | 409.99 | 403.57 | 232.89 | 245.1 | 224.99 | 207.22 | 210.2 | 191.28 | 141.93 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 273.89 | 193.46 | 163.87 | 157 | 140.72 | 125.74 | 114.06 | 100.74 | 91.45 | 81.9 |
Less : Accumulated Depreciation | 94.85 | 84.05 | 72.69 | 61.06 | 72.29 | 63.81 | 55.84 | 44.55 | 35.4 | 26.62 |
Net Block | 179.04 | 109.41 | 91.18 | 95.94 | 68.43 | 61.93 | 58.22 | 56.19 | 56.05 | 55.28 |
Capital Work in Progress | 5.71 | 14.78 | 8.01 | 0.04 | 0 | 4.58 | 10.51 | 15.14 | 9.15 | 0 |
Investments | 173.44 | 106.55 | 64.86 | 23.18 | 120.98 | 120.98 | 123.47 | 121.22 | 95.22 | 10.22 |
Inventories | 62.19 | 74.74 | 58.71 | 41.46 | 49.32 | 19.03 | 26.51 | 39.9 | 27.1 | 32.21 |
Sundry Debtors | 136.28 | 116.86 | 110.77 | 79.41 | 64.56 | 62.26 | 59.47 | 60.69 | 55.22 | 67.86 |
Cash and Bank Balance | 30.9 | 25.45 | 113.81 | 30.96 | 18.38 | 13.2 | 5.61 | 2.21 | 28.99 | 7.86 |
Loans and Advances | 28.44 | 29.97 | 33.52 | 19.18 | 14.11 | 5.6 | 7.27 | 1.97 | 3.16 | 3.91 |
Total Current Assets | 257.8 | 247.03 | 316.81 | 171.01 | 146.36 | 100.08 | 98.85 | 104.77 | 114.46 | 111.85 |
Current Liabilities | 169 | 117.97 | 87.13 | 62.14 | 98.29 | 67.44 | 86.7 | 92.81 | 89.75 | 58.11 |
Provisions | 0.73 | 1.04 | 0.33 | 0.28 | 0.41 | 4.58 | 4.92 | 0.72 | 0.07 | 0.02 |
Total Current Liabilities & Provisions | 169.72 | 119.01 | 87.46 | 62.42 | 98.7 | 72.02 | 91.62 | 93.53 | 89.83 | 58.13 |
Net Current Assets | 88.08 | 128.01 | 229.35 | 108.58 | 47.67 | 28.06 | 7.23 | 11.24 | 24.64 | 53.72 |
Deferred Tax Assets | 3.32 | 3.65 | 3.07 | 0 | 1.97 | 1.84 | 1.65 | 0.47 | 0.69 | 0 |
Deferred Tax Liability | 2.75 | 1.63 | 1.04 | 0.68 | 0 | 0 | 0 | 0 | 0 | 0.16 |
Net Deferred Tax | 0.57 | 2.02 | 2.03 | -0.68 | 1.97 | 1.84 | 1.65 | 0.47 | 0.69 | -0.16 |
Other Assets | 9.59 | 49.23 | 8.13 | 5.84 | 6.06 | 7.6 | 6.14 | 5.92 | 5.53 | 22.86 |
Total Assets | 456.44 | 410 | 403.57 | 232.9 | 245.11 | 224.99 | 207.22 | 210.18 | 191.28 | 141.92 |
Contingent Liabilities | 0 | 0 | 2.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 77.09 |
Depreciation | 13.44 |
Interest (Net) | -0.86 |
P/L on Sales of Assets | -0.01 |
Prov. and W/O (Net) | 2.75 |
P/L in Forex | -0.01 |
Others | -4.02 |
Total Adjustments (PBT and Ext... | 6.56 |
Operating Profit before Workin... | 83.66 |
Trade and 0ther Receivables | -19.84 |
Inventories | 12.55 |
Trade Payables | 43.77 |
Total Adjustments (OP before W... | 43.95 |
Cash Generated from/(used in) ... | 127.61 |
Direct Taxes Paid | -18.65 |
Total Adjustments(Cash Generat... | -18.65 |
Cash Flow before Extraordinary... | 108.96 |
Net Cash from Operating Activi... | 108.96 |
Purchased of Fixed Assets | -37.68 |
Sale of Fixed Assets | 0.04 |
Purchase of Investments | -56.17 |
Interest Received | 1.74 |
Net Cash used in Investing Act... | -92.07 |
Of the Long Tem Borrowings | -0.11 |
Of the Short Term Borrowings | -0.23 |
Of Financial Liabilities | -1.52 |
Dividend Paid | -8.3 |
Interest Paid | -1.11 |
Net Cash used in Financing Act... | -15.29 |
Net Profit before Tax and Extr... | 77.02 |
Depreciation | 13.44 |
Interest (Net) | -0.87 |
P/L on Sales of Assets | -0.01 |
Prov. and W/O (Net) | 2.78 |
Others | -4.02 |
Total Adjustments (PBT and Ext... | 6.6 |
Operating Profit before Workin... | 83.62 |
Trade and 0ther Receivables | -19.84 |
Inventories | 12.55 |
Trade Payables | 43.73 |
Total Adjustments (OP before W... | 43.91 |
Cash Generated from/(used in) ... | 127.53 |
Direct Taxes Paid | -18.62 |
Total Adjustments(Cash Generat... | -18.62 |
Cash Flow before Extraordinary... | 108.91 |
Net Cash from Operating Activi... | 108.91 |
Purchased of Fixed Assets | -37.68 |
Sale of Fixed Assets | 0.04 |
Purchase of Investments | -56.17 |
Interest Received | 1.74 |
Net Cash used in Investing Act... | -92.07 |
Of the Long Tem Borrowings | -0.11 |
Of the Short Term Borrowings | -0.23 |
Of Financial Liabilities | -1.52 |
Dividend Paid | -8.3 |
Interest Paid | -1.11 |
Net Cash used in Financing Act... | -15.29 |
Company Details
Registered Office |
|
Address | 40/1 Mohabewala Industrial, Area |
City | Dehradun |
State | Uttarakhand |
Pin Code | 248110 |
Tel. No. | 91-135-6608000 |
Fax. No. | |
grievance@windlasbiotech.com | |
Internet | http://www.windlasbiotech.com |
Registrars |
|
Address | 40/1 Mohabewala Industrial |
City | Dehradun |
State | Uttarakhand |
Pin Code | 248110 |
Tel. No. | 91-135-6608000 |
Fax. No. | |
grievance@windlasbiotech.com | |
Internet | http://www.windlasbiotech.com |
Management |
|
Name | Designation |
Vivek Dhariwal | Chairman & Independent Directo |
Ashok Kumar Windlass | Whole-time Director |
Hitesh Windlass | Managing Director |
Manoj Kumar Windlass | Joint Managing Director |
Pawan Kumar Sharma | Executive Director |
Prachi Jain Windlass | Non-Exec & Non-Independent Dir |
Srinivasan Venkataraman | Non-Exec. & Independent Dir. |
Gaurav Gulati | Non-Exec. & Independent Dir. |
Ananta Narayan Panda | Company Sec. & Compli. Officer |